As a result of the above-mentioned RNA-seq analysis, it was observed that PXN-AS1 was upregulated in the samples of CML patients who were resistant to Imatinib (Fig. 4a, b). The gene discussed is PXN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.